Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings

Shares (Q2 2026)
1,733,801
Value
$44.0M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of PCRX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,733,801$44.0M0.1%−91,700−5.0%ReducedHolders
Q1 20261,825,501$41.3M0.1%−58,500−3.1%ReducedHolders
Q4 20251,884,001$48.8M0.1%−254,200−11.9%ReducedHolders
Q3 20252,138,201$55.1M0.1%−257,400−10.7%ReducedHolders
Q2 20252,395,601$57.3M0.1%+155,000+6.9%AddedHolders
Q1 20252,240,601$55.7M0.1%+248,000+12.4%AddedHolders
Q4 20241,992,601$37.5M0.1%+13,604+0.7%AddedHolders
Q3 20241,978,997$29.8M<0.1%−87,200−4.2%ReducedHolders
Q2 20242,066,197$59.1M0.1%+184,000+9.8%AddedHolders
Q1 20241,882,197$55.0M0.1%+165,500+9.6%AddedHolders
Q4 20231,716,697$57.9M0.1%+102,700+6.4%AddedHolders
Q3 20231,613,997$49.5M0.1%+39,300+2.5%AddedHolders
Q2 20231,574,697$63.1M0.1%+15,800+1.0%AddedHolders
Q1 20231,558,897$63.6M0.1%−28,200−1.8%ReducedHolders
Q4 20221,587,097$61.3M0.1%−166,400−9.5%ReducedHolders
Q3 20221,753,497$93.3M0.1%−212,000−10.8%ReducedHolders
Q2 20221,965,497$114.6M0.1%+104,500+5.6%AddedHolders
Q1 20221,860,997$142.0M0.2%+11,800+0.6%AddedHolders
Q4 20211,849,197$111.3M0.1%−119,600−6.1%ReducedHolders
Q3 20211,968,797$110.3M0.1%−91,530−4.4%ReducedHolders
Q2 20212,060,327$125.0M0.2%−254,470−11.0%ReducedHolders
Q1 20212,314,797$162.2M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.